Cargando…
Does Cytomegalovirus Develop Resistance following Antiviral Prophylaxis and Treatment in Renal Transplant Patients in Kuwait?
The resistance of cytomegalovirus (CMV) to ganciclovir or valganciclovir is a factor in therapeutic failure and disease progression. CMV strains resistant to ganciclovir or valganciclovir have been associated with specific mutations in the UL97 and UL54 genes. Sequencing of both CMV UL97 and UL54 ge...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265297/ https://www.ncbi.nlm.nih.gov/pubmed/22312337 http://dx.doi.org/10.1155/2011/260561 |
_version_ | 1782222068435124224 |
---|---|
author | Madi, Nada Al-Nakib, Widad Pacsa, Alexander |
author_facet | Madi, Nada Al-Nakib, Widad Pacsa, Alexander |
author_sort | Madi, Nada |
collection | PubMed |
description | The resistance of cytomegalovirus (CMV) to ganciclovir or valganciclovir is a factor in therapeutic failure and disease progression. CMV strains resistant to ganciclovir or valganciclovir have been associated with specific mutations in the UL97 and UL54 genes. Sequencing of both CMV UL97 and UL54 genes was performed to detect the presence of CMV antiviral resistance in six patients who received ganciclovir (and/or valganciclovir) and had prolonged detectable CMV DNA in their blood during antiviral treatment. Sequencing results showed no specific mutations in either UL97 or UL54 gene of CMV and therefore the CMV strains in kidney transplant patients who received ganciclovir either prophylactically or therapeutically were from the wild type. Our results suggest that CMV management and immunosuppression protocols for kidney transplant patients followed in the Organ Transplant Centre, Kuwait, is very effective in reducing the opportunity of developing CMV antiviral resistance. |
format | Online Article Text |
id | pubmed-3265297 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-32652972012-02-06 Does Cytomegalovirus Develop Resistance following Antiviral Prophylaxis and Treatment in Renal Transplant Patients in Kuwait? Madi, Nada Al-Nakib, Widad Pacsa, Alexander Adv Virol Research Article The resistance of cytomegalovirus (CMV) to ganciclovir or valganciclovir is a factor in therapeutic failure and disease progression. CMV strains resistant to ganciclovir or valganciclovir have been associated with specific mutations in the UL97 and UL54 genes. Sequencing of both CMV UL97 and UL54 genes was performed to detect the presence of CMV antiviral resistance in six patients who received ganciclovir (and/or valganciclovir) and had prolonged detectable CMV DNA in their blood during antiviral treatment. Sequencing results showed no specific mutations in either UL97 or UL54 gene of CMV and therefore the CMV strains in kidney transplant patients who received ganciclovir either prophylactically or therapeutically were from the wild type. Our results suggest that CMV management and immunosuppression protocols for kidney transplant patients followed in the Organ Transplant Centre, Kuwait, is very effective in reducing the opportunity of developing CMV antiviral resistance. Hindawi Publishing Corporation 2011 2011-03-24 /pmc/articles/PMC3265297/ /pubmed/22312337 http://dx.doi.org/10.1155/2011/260561 Text en Copyright © 2011 Nada Madi et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Madi, Nada Al-Nakib, Widad Pacsa, Alexander Does Cytomegalovirus Develop Resistance following Antiviral Prophylaxis and Treatment in Renal Transplant Patients in Kuwait? |
title | Does Cytomegalovirus Develop Resistance following Antiviral Prophylaxis and Treatment in Renal Transplant Patients in Kuwait? |
title_full | Does Cytomegalovirus Develop Resistance following Antiviral Prophylaxis and Treatment in Renal Transplant Patients in Kuwait? |
title_fullStr | Does Cytomegalovirus Develop Resistance following Antiviral Prophylaxis and Treatment in Renal Transplant Patients in Kuwait? |
title_full_unstemmed | Does Cytomegalovirus Develop Resistance following Antiviral Prophylaxis and Treatment in Renal Transplant Patients in Kuwait? |
title_short | Does Cytomegalovirus Develop Resistance following Antiviral Prophylaxis and Treatment in Renal Transplant Patients in Kuwait? |
title_sort | does cytomegalovirus develop resistance following antiviral prophylaxis and treatment in renal transplant patients in kuwait? |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265297/ https://www.ncbi.nlm.nih.gov/pubmed/22312337 http://dx.doi.org/10.1155/2011/260561 |
work_keys_str_mv | AT madinada doescytomegalovirusdevelopresistancefollowingantiviralprophylaxisandtreatmentinrenaltransplantpatientsinkuwait AT alnakibwidad doescytomegalovirusdevelopresistancefollowingantiviralprophylaxisandtreatmentinrenaltransplantpatientsinkuwait AT pacsaalexander doescytomegalovirusdevelopresistancefollowingantiviralprophylaxisandtreatmentinrenaltransplantpatientsinkuwait |